The Leukemia Service at Roswell Park Cancer Institute (RPCI) is dedicated to quality patient care, innovative research, and the development of more effective treatments for all hematologic malignancies, including
- Acute lymphoblastic leukemia (ALL)
- Acute myeloid leukemia (AML)
- Chronic myeloid leukemia (CML)
- Myelodysplastic syndrome (MDS)
- Myeloproliferative neoplasms (MPN)
RPCI’s Leukemia Service takes a team approach to patient care. A leukemia physician oversees a team of fellows, nurse practitioners, physician assistants, pharmacists, social workers, a discharge-planning coordinator, a psychologist and research coordinators. Our nurse practitioner/physician assistant-run clinic in the Chemotherapy/Infusion Center is designed to see patients receiving outpatient chemotherapy or those who have low blood counts and are in need of transfusions.
Clinical research conducted by our faculty and staff consistently translates into new therapeutic approaches and advances overall knowledge of the disease.
Accurate diagnosis is critical for appropriate treatment. 10% of patients receive a different diagnosis after coming to RPCI, as a result of the specialized expertise of the Pathology team at RPCI.